Please wait while the formulary information is being retrieved.
CORTISPORIN (NEOMYCIN SULFATE/POLYMYXIN B SULFATE/HYDROCORTISONE)
- Minor bacterial skin infections
- Skin inflammation
1 % topical ointment
- Apply a thin layer to the affected area(s) by topical route 2 times per day
3.5 mg/g-10,000 unit/g-0.5 % topical cream
- Apply a thin layer to the affected area(s) by topical route 2 times per day
Minor bacterial skin infections
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 3 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
Skin inflammation
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 3 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Severe burns
Severe
Moderate
- Hypothalamic-pituitary insufficiency
- Large open wound
- No disease contraindications
CORTISPORIN (NEOMYCIN SULFATE/POLYMYXIN B SULFATE/HYDROCORTISONE)
- Minor bacterial skin infections
- Skin inflammation
- Dermatitis due to topical drug
- Skin rash
- Erythema
- Stinging of skin
More Frequent
Severe
Less Severe
- Folliculitis
- Purpura
- Skin and skin structure infection
- Skin atrophy
- Headache disorder
- Paresthesia
- Pruritus of skin
- Skin rash
- Telangiectasia
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenal cortical insufficiency
- Anaphylaxis
- Bullous dermatitis
- Cataracts
- Central serous chorioretinopathy
- Glaucoma
- Hypothalamic-pituitary insufficiency
- Ocular hypertension
- Ototoxicity
- Skin hypopigmentation
- Skin striae
- Skin ulcer
- Urticaria
Less Severe
- Acneiform eruption
- Alopecia
- Blistering skin
- Contact dermatitis
- Dry skin
- Dyschromia
- Fungal infection of skin
- Glycosuria
- Hirsutism
- Hypercortisolism
- Hyperesthesia
- Hyperglycemia
- Miliaria
- Perioral dermatitis
- Skin irritation
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hydrocortisone (Top,Ophth,Rect)
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
- 1 Day – 18 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Bacitracin (ophth,top)
- Severity Level:
2
- Additional Notes: Insufficient data available.
Hydrocortisone (topical, Non-systemic)
- Severity Level:
2
- Additional Notes: Systemic absorption unknown; insuff human data
Neomycin (topical)
- Severity Level:
2
- Additional Notes: Insufficient data available for topical product.
Polymyxin B Sulfate (ophth,otic,top)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Bacitracin (inj,top,ophth)
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
Neomycin (topical, Ophth)
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
Polymyxin B
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
Hydrocortisone (top., Rectal)
Insufficient data available; limited use may pose little risk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Insufficient data available; limited use may pose little risk |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Minor bacterial skin infections | |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| Skin inflammation | |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
| 0-9 | A-Z |
|---|---|
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
Formulary Reference Tool